*AF + Stable CAD: OAC Alone or with SAPT? 🤔* 📌 Meta-analysis (4 RCTs, 4,092 patients) compared OAC monotherapy vs OAC + SAPT in patients with AF + stable CAD. *💡 Key Findings:* • No significant difference in ischaemic events (MI, stroke, embolism, death). • OAC monotherapy significantly reduced major bleeding (3.3% vs 5.7%). • Greater bleeding reduction in men & diabetics. *🩺 Clinical Takeaway:* 🔹 OAC monotherapy may be a safer long-term strategy in AF + stable CAD. https://www.sciencedirect.com/science/article/abs/pii/S0735109725000713?via%3Dihub